We can help you get approved medicine that isn't approved or available in your home country.. To learn more, fill out the form below.
EMPLICITI@ is a SLAMF7-directed immunostimulatory antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies
The information provided herein is not medical advice and is not intend to replace medical advice offered by a health care provider. Please consult your health care provider for advice.
Trade Partners
Franchise
Download PDF
+91-9953494942